Who makes Bupivacaine Injectable Product?

Bupivacaine Injectable Product is developed by Fraser Health.

What development phase is Bupivacaine Injectable Product in?

Bupivacaine Injectable Product is in Phase 1.

What are the side effects of Bupivacaine Injectable Product?

Common side effects include Nausea, Dizziness, Constipation, Headache, Vomiting, Motor dysfunction.

Last reviewed 2026-04-20 · How we verify

Bupivacaine Injectable Product

Fraser Health · Phase 1 active Small molecule Quality 10/100

Bupivacaine Injectable Product is a local anesthetic used for various surgical procedures and pain management. It has a robust clinical trial pipeline, including Phase 2 and 3 studies, and is widely used off-label for conditions like postoperative pain and nerve blocks. The drug's safety profile includes common side effects such as nausea and dizziness, and it faces competition from other local anesthetics.

At a glance

Generic name	Bupivacaine Injectable Product
Sponsor	Fraser Health
Modality	Small molecule
Phase	Phase 1

Approved indications

No approved indications tracked.

Common side effects

Nausea
Dizziness
Constipation
Headache
Vomiting
Motor dysfunction
Bradycardia
Incision site oedema
Pyrexia
Dysgeusia
Incision site erythema
Post procedural contusion